Is Trazodone Habit-Forming? Dependence vs. Addiction

Trazodone is not considered habit-forming in the way that classic sleep medications like benzodiazepines or Z-drugs are. It does not produce the “high” or euphoric feeling that drives drug-seeking behavior, and research shows it scores significantly lower on measures of abuse potential compared to commonly prescribed sleep aids. That said, your body can adjust to trazodone over time, and stopping abruptly can cause uncomfortable withdrawal symptoms, so the answer is more nuanced than a simple no.

Why Trazodone Differs From Addictive Sleep Aids

Trazodone belongs to a class called SARIs, which work primarily by blocking certain serotonin receptors and preventing serotonin from being reabsorbed too quickly. This is a fundamentally different mechanism from benzodiazepines (like triazolam) or Z-drugs (like zolpidem), which target the same brain receptors as alcohol and produce sedation through a pathway closely linked to reward and euphoria.

In a head-to-head study measuring abuse potential, participants who took trazodone rated it lower on “willing to take again” scores compared to triazolam. Zolpidem and triazolam, by contrast, performed similarly to each other on abuse-related measures, with the highest dose of zolpidem actually increasing ratings of liking, happiness, and elation. The researchers concluded that trazodone has less abuse potential than triazolam and may be a viable alternative for people with a history of alcohol or drug problems.

At the low doses typically used for sleep (25 to 100 mg), trazodone works mainly by blocking histamine and certain serotonin receptors that promote wakefulness. It doesn’t activate the brain’s reward circuitry the way habit-forming sedatives do, which is why people generally don’t develop cravings for it or escalate their dose to chase a feeling.

Tolerance at Sleep Doses

One concern with any sleep medication is whether it stops working over time, pushing you to take more. At low sleep doses, trazodone does not appear to cause significant tolerance. Its relatively short half-life of 3 to 6 hours means it clears the body quickly, which helps maintain its effectiveness night after night without requiring dose increases. At higher antidepressant doses, some tolerance to certain effects can develop, but this is a different clinical scenario than using it as a sleep aid.

That said, one systematic review found that trazodone’s ability to help people fall asleep faster diminished by the second week of use in at least one trial, performing comparably to placebo on sleep onset time while still helping with overall sleep maintenance. So while it doesn’t drive the kind of dose escalation seen with addictive drugs, its sleep benefits may shift over time in ways worth discussing with a prescriber.

Withdrawal Is Real, Even Without Addiction

Trazodone can cause a discontinuation syndrome if you stop taking it suddenly, especially after weeks or months of regular use. This does not mean you’re addicted. Physical dependence (your body adjusting to a drug’s presence) and addiction (compulsive use despite harm) are different things. Many non-addictive medications, including certain blood pressure drugs and antidepressants, cause withdrawal if stopped abruptly.

Reported withdrawal symptoms from trazodone include dizziness, nausea, headache, confusion, anxiety, agitation, difficulty sleeping, extreme tiredness, sweating, ringing in the ears, and tingling or burning sensations in the hands or feet. In rare cases, seizures have been reported. These symptoms can be avoided or minimized by tapering the dose gradually rather than stopping cold turkey. A prescriber will typically reduce your dose in steps over days or weeks depending on how long you’ve been taking it and at what dose.

A Special Concern for People in Alcohol Recovery

There’s one population where trazodone raises a more specific red flag. When your body breaks down trazodone, it produces a metabolite called mCPP. Multiple studies have found that this metabolite can increase alcohol cravings in people with alcohol use disorder. In one study, 21 people with alcohol use disorder received mCPP after three weeks of abstinence. Eleven reported a “high” feeling similar to alcohol, and seven reported an urge to drink. Other trials have replicated this finding, showing that mCPP modestly but significantly increased alcohol cravings compared to placebo.

This doesn’t mean trazodone is addictive in the traditional sense, but it does suggest it could undermine sobriety efforts for some people recovering from alcohol problems. If that applies to you, this is worth raising with your provider.

Next-Day Effects

Part of what makes a sleep aid problematic is whether it leaves you impaired the next day, creating a cycle where you feel you need it to function. Trazodone’s short half-life generally works in its favor here. Several studies have found no significant hangover effect at typical sleep doses. One study of 25 mg taken over 9 days found no measurable cognitive impairment in healthy men. However, a single 100 mg dose did impair driving-related cognitive performance about 2 hours after taking it, and a 50 mg dose caused small short-term memory impairments after one week of use. The takeaway: at lower doses, next-day grogginess is unlikely, but higher doses or early-in-treatment effects can cause some fogginess.

Where Sleep Medicine Stands on Trazodone

Despite its widespread off-label use for insomnia, the American Academy of Sleep Medicine issued a weak recommendation against using trazodone for sleep onset or sleep maintenance insomnia. This isn’t because of addiction concerns. It reflects limited high-quality evidence that trazodone works well enough for insomnia compared to other options, and some inconsistency in how long its benefits last. Many clinicians still prescribe it for sleep precisely because it carries lower abuse risk than alternatives, making it a pragmatic choice even if the formal evidence base is thinner than ideal.

In practice, trazodone occupies an unusual space: it’s one of the most commonly prescribed sleep aids in the United States largely because it avoids the dependency problems of stronger sedatives, even though the sleep medicine establishment considers the evidence supporting it to be modest. For people concerned about habit-forming medications, that tradeoff is often exactly why their doctor chose it.